Back to Search Start Over

Non-collagen genes role in digenic Alport syndrome

Authors :
Chiara Fallerini
Alessandra Renieri
Mirella Bruttini
Simone Furini
Sergio Daga
Anna Maria Pinto
Francesca Mari
Francesco Scolari
Maria Antonietta Mencarelli
Francesca Ariani
Carmine Pecoraro
Source :
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019), BMC Nephrology
Publication Year :
2019
Publisher :
BMC, 2019.

Abstract

Background Alport syndrome is a clinically heterogeneous nephropathy characterized by severe symptomatology at kidney level due to ultrastructural lesions of the glomerular basement membrane (GBM) as consequence of mutations in COL4 genes. The disease has been linked to COL4A3/COL4A4/COL4A5 mutations, which impair GBM functionality and can be inherited in a dominant, recessive or X-linked transmission. Although a targeted Next Generation Sequencing approach has allowed identifying families with pathogenic mutations in more than one COL4 α3-α4-α5 heterotrimer encoding genes, leading to conclude for a digenic pattern of inheritance, the role of non-collagen genes in digenic Alport syndrome has not yet been established. Methods We employed a whole-exome sequencing approach on three families in whom a digenic pattern of transmission could be suspected because of a likely biparental contribution or an unexplained phenotype in the proband. Results We identified in the three probands hypomorphic LAMA5 mutations co-inherited with pathogenic COL4 α4-α5 chains mutations. Segregation analysis revealed that the combination of LAMA5/COL4 variants co-segregate with a fully penetrant phenotype in line with a digenic inheritance. In one of the three probands an hypomorphic variant in NPHS2 was also found, suggesting that role of other kidney disease related-genes as modifiers. Conclusion These findings validate the impact of LAMA5 mutations in digenic ATS and highlight the role of extracellular matrix’s genes, basement membrane, slit diaphragm and podocyte cytoskeleton in ATS. This underline the need for a more extensive panel approach in the presence of a digenic ATS, in order to better define clinical severity and recurrence risk for family members. Electronic supplementary material The online version of this article (10.1186/s12882-019-1258-5) contains supplementary material, which is available to authorized users.

Details

Language :
English
ISSN :
14712369
Volume :
20
Issue :
1
Database :
OpenAIRE
Journal :
BMC Nephrology
Accession number :
edsair.doi.dedup.....fd0d578804048f21a669af7aa7a59f38